Chemours (NYSE:CC) PT Raised to $28.00 at UBS Group
Chemours (NYSE:CC – Get Free Report) had its price objective raised by investment analysts at UBS Group from $21.00 to $28.00 in a research report issued on Tuesday, Benzinga reports. The firm presently has a “neutral” rating on the specialty chemicals company’s stock. UBS Group’s price target points to a potential upside of 1.38% from […]